FDA Investigator Kelly Doremus

Kelly Doremus has inspections in 3 countries as of 31 Oct 2023. Kelly Doremus has collaborated with a combinined 1952 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
121
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Argentina, Brazil
Co-Investigator(s):
Alberto A Viciedo, Allen Lou, Amy M Cramer, Amy W Yan Mai, Ana S Cabrera, Andrew J Molesky, Anthony M Criscuolo, Jr, Barbara J Maulfair, Barbara Jwilimczyk Macri, Cary Greene, Charisse K Green, Charles J Chacko, Charlotte P Chang, Christina N Maurino, Colin E Tack, Craig W Swanson, Crystal A Harlan, Daniel W Johnson, David H Smith, Dhaval H Patel, Diane B Radice, Donyel M Jones, Doreen P Canetti, Doreen P Gubbay, Edward D Mcdonald, Edward Oshaughnessy, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Frank J Marciniak, Frank J Mariciniak, Gabriel Feng, Gale L Glinecki, Gianine E Delade, Gianine E Thompkins, Gianine E Tompkins, Helen B Ricalde, Helen Verdel, Herrmann, Jacqueline A O'shaughnessy, PhD, Jananiga Vanniyasingam, Jason M Sluzynski, Jennifer Macmillan, Jessica M Monteiro, Jill M Sooter, Jogy George, Jose V Obando, Joseph F Mcginnis, RPh, Joseph H Procopio, Joseph S Fanelli, Karen E D'orazio, Kazi Rafiquzzaman, Keith M Reilly, Kelli F Dobilas, Kelly I Anderson, Kerry A Kurdilla, King, Kinh Q Mac, Kris K Moore, Kristen E Rescigno, Krystal O Ogunremi, Kwong P Lee, Kyle D Covill, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, Li Li, Liatte Kreuger, PharmD, Lisa B Hall, Marcelo O Mangalindan, Jr, Marjorie D Schultz, Matthew W Kyle, Melba T Rivera, Melba Trivera Clavell, Melissa A Freeman, Melissa B Libby, Meredith L Sheridan, Meyer, Miguel G Manzano, Nicholas E Squillante, Nicholas J Morici, Nikki S Ramirez, Paterson, Randolph Campos Santiago, Raymond L Cheung, Remache, Richard D Manney, Robert G Ruff, Rodrigo Vilchez, Saleem A Akhtar, Sandra Kershaw, Sands, Schultz, Sherri J Liu, Shreya Shah, Sinai Davis, State Agency, Stephanie T Durso, Stephen J Mottola, Steven M Weinman, Susan M Halsted, Tania E Vizcaino, Tara G Bizjak, Tara K Carmody, Teigan M Mule, Tonia F Bernard, Tressa T Lewis, Valerie C Reed, Wayne J Meyer, William J Muszynski, William R Chang, Willy A Orantes, Zakaria I Ganiyu

Kelly Doremus's Documents

Publish Date Document Type Title
August, 2010 EIR Queseria Chipilo, Inc. - EIR, 2010-08-18
April, 2009 FDA 483 Maquet Cardiovascular, LLC - Form 483, 2009-04-17
April, 2009 EIR Maquet Cardiovascular, LLC - EIR, 2009-04-17
June, 2009 FDA 483 D.M. Davis Incorporated - Form 483, 2009-06-09
September, 2010 EIR Queseria Chipilo, Inc. - EIR, 2010-09-23
September, 2012 FDA 483 Response N.V.E. Pharmaceuticals, Inc. - Form 483R, 2013-01-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more